% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Zhang:169296,
author = {K. S. Zhang$^*$ and P. Schelb$^*$ and S. Kohl$^*$ and J. P.
Radtke$^*$ and M. Wiesenfarth$^*$ and L. Schimmöller and T.
A. Kuder$^*$ and A. Stenzinger and M. Hohenfellner and H.-P.
Schlemmer$^*$ and K. Maier-Hein$^*$ and D. Bonekamp$^*$},
title = {{I}mprovement of {PI}-{RADS}-dependent prostate cancer
classification by quantitative image assessment using
radiomics or mean {ADC}.},
journal = {Magnetic resonance imaging},
volume = {82},
issn = {0730-725X},
address = {Amsterdam [u.a.]},
publisher = {Elsevier Science},
reportid = {DKFZ-2021-01393},
pages = {9-17},
year = {2021},
note = {#EA:E010#LA:E010# / 2021 Jun 18;82:9-17},
abstract = {Background Currently, interpretation of prostate MRI is
performed qualitatively. Quantitative assessment of the mean
apparent diffusion coefficient (mADC) is promising to
improve diagnostic accuracy while radiomic machine learning
(RML) allows to probe complex parameter spaces to identify
the most promising multi-parametric models. We have
previously developed quantitative RML and ADC classifiers
for prediction of clinically significant prostate cancer
(sPC) from prostate MRI, however these have not been
combined with radiologist PI-RADS assessment. Purpose To
propose and evaluate diagnostic algorithms combining
quantitative ADC or RML and qualitative PI-RADS assessment
for prediction of sPC. Methods and population The previously
published quantitative models (RML and mADC) were utilized
to construct four algorithms: 1) Down(ADC) and 2) Down(RML):
clinically detected PI-RADS positive prostate lesions
(defined as either PI-RADS≥3 or ≥4) were downgraded to
MRI negative upon negative quantitative assessment; and 3)
Up(ADC) and 4) Up(RML): MRI-negative lesions were upgraded
to MRI-positive upon positive assessment of quantitative
parameters. Analyses were performed at the individual lesion
level and the patient level in 133 consecutive patients with
suspicion for clinically significant prostate cancer (sPC,
International Society of Urological Pathology (ISUP) grade
group≥2), the test set subcohort of a previously published
patient population. McNemar test was used to compare
differences in sensitivity, specificity and accuracy.
Differences between lesions of different prostate zones were
assessed using ANOVA. Reduction in false positive
assessments was assessed as ratios. Results Compared to
clinical assessment at the PI-RADS≥4 cut-off alone,
algorithms Down(ADC/RML) improved specificity from $43\%$ to
$65\%$ (p = $0.001)/62\%$ (p = 0.003), while sensitivity did
not change significantly at $89\%$ compared to $87\%$ (p =
$1.0)/89\%$ (unchanged) on the patient level. Reduction of
false positive lesions was $50\%$ [26/52] in the PZ and
$53\%$ [15/28] in the TZ. Algorithms Up(ADC/RML) led, on a
patient basis, to an unfavorable loss of specificity from
$43\%$ to $30\%$ (p = $0.039)/32\%$ (p = 0.106), with
insignificant increase of sensitivity from $89\%$ to
$96\%/96\%$ (both p = 1.0). Compared to clinical assessment
at the PI-RADS≥3 cut-off alone, similar results were
observed for Down(ADC) with significantly increased
specificity from $2\%$ to $23\%$ (p < 0.001) and unchanged
sensitivity on the lesion level; patient level specificity
increased only non-significantly. Conclusion Downgrading
PI-RADS≥3 and ≥ 4 lesions based on quantitative mADC
measurements or RML classifiers can increase diagnostic
accuracy by enhancing specificity and preserving sensitivity
for detection of sPC and reduce false positives.},
keywords = {ADC (Other) / MRI (Other) / PI-RADS (Other) / Prostate
cancer (Other) / Radiomics (Other)},
cin = {E010 / E230 / C060 / E020 / HD01},
ddc = {610},
cid = {I:(DE-He78)E010-20160331 / I:(DE-He78)E230-20160331 /
I:(DE-He78)C060-20160331 / I:(DE-He78)E020-20160331 /
I:(DE-He78)HD01-20160331},
pnm = {315 - Bildgebung und Radioonkologie (POF4-315)},
pid = {G:(DE-HGF)POF4-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:34147597},
doi = {10.1016/j.mri.2021.06.013},
url = {https://inrepo02.dkfz.de/record/169296},
}